Walkasins to improve balance for people with peripheral neuropathy
Official title: Balance4Mobility: Effects of Walkasins Use on Clinical Outcomes of Gait and Balance Function in Individuals With Peripheral Neuropathy and Balance Problems - A Randomized Control Trial
Run by RxFunction Inc. · NCT06959277 · Data updated 2026-11-12
This project will test whether daily use of Walkasins helps people with peripheral neuropathy improve foot-placement awareness and balance over six months.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 55 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | RxFunction Inc. Industry-sponsored |
| Drugs / interventions | chemotherapy |
| Locations | 6 sites (Mesa, Arizona and 5 other locations) |
| Status | Recruiting |
| Started | June 17, 2025 |
| Main results expected | December 10, 2027 |
| Study ends | June 2028 |
| Registry record updated | October 5, 2026 |
| Trial ID | NCT06959277 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 55 or older with a clinical diagnosis of chronic peripheral neuropathy (including chemo-induced PN at least one year post-chemotherapy), self-reported balance or gait problems, appropriate foot size for the device, and the ability to complete functional outcome measures without an assistive device.
✕Probably not a fit
People with near-normal balance (for example able to stand on one leg for 30 seconds), active acute vascular conditions like thrombophlebitis or DVT, incompatible foot size, or those who require assistive devices for testing are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, controlled comparison of daily Walkasins use versus no device across multiple U.S. clinical sites over a six-month period. Eligible participants are adults 55 and older with chronic peripheral neuropathy and self-reported balance or gait problems who can complete functional tests without an assistive device. Study procedures include baseline and periodic timed standing and walking tests, questionnaires about balance and falls, regular clinic visits and phone calls, and daily use of the Walkasins device for those assigned to it. Control-group participants are offered the device after six months, and outcomes include self-reported foot-placement awareness plus objective measures such as gait speed and functional balance tests.
Why it matters
Potential benefit: If successful, Walkasins could improve balance and gait speed and reduce fall risk in people with peripheral neuropathy.
How similar studies have gone: Prior published work, including a randomized crossover in PLOS ONE and the multi-site walk2Wellness trial, reported clinically meaningful improvements in gait speed and functional balance and reductions in fall rates with Walkasins use.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Able to understand and provide informed consent for him or herself * Age 55 and older, male or female * Able to complete all functional outcome measures without the use of an assistive device * Clinical diagnosis of peripheral neuropathy prior to participating in the study as documented in the participant's medical record or by physician's note. Individuals with chemo-induced peripheral neuropathy must be at least one-year post-chemotherapy, indicating that their PN has become a chronic condition. * Self-reported gait and balance problems * Foot size that allows the Walkasins to function appropriately * Willing to use the Walkasins device as recommended Exclusion Criteria: * Ability to stand on one leg for at least 30 seconds (If the person can stand for at least 30 seconds, he/she is excluded because his/her balance is likely not impaired enough to benefit from Walkasins.) * Self-reported acute thrombophlebitis, including deep vein thrombosis * Self-reported severe peripheral vascular disease * Untreated lymphedema * Untreated lesion of any kind, swelling, infection, inflamed area of skin or eruptions on the lower leg near product use * Self-reported, untreated fractures in the foot and ankle * Other neurological or musculoskeletal conditions that moderately or severely impact walking * Use of ankle-foot orthosis for ambulation that prevents donning of Walkasins * Weight of more than 300 pounds * Inability to perceive vibration from Walkasins Haptic Module
Where it's running
-
Fairview Frontiers
Saint Paul, Minnesota, United States Recruiting -
Dent Neurologic Institute
Amherst, New York, United States Recruiting -
University of Pittsburgh
Pittsburgh, Pennsylvania, United States Recruiting -
University of Texas Medical Branch
Galveston, Texas, United States Recruiting -
OrthoArizona--Mesa Arbor Avenue
Mesa, Arizona, United States Active not recruiting -
Marcus Institute for Aging Research, Hebrew SeniorLife
Boston, Massachusetts, United States Active not recruiting
Study contacts
- Study coordinator: Clinical Research Project Manager
- Email: research@rxfunction.com
- Phone: 612-358-2141
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
LiFE-SePBT: A Friendly Balance Program to Help Older Adults Stay Steady at Home
We’re testing whether a light, lifestyle-based balance exercise program with small perturbations can improve balance for older adults who are at risk of falling.
-
Movement improves balance and touch in older adults with type 2 diabetes
This study tests whether a 12-week exercise program, with or without extra balance training, can improve balance for people 60 and older with type 2 diabetes.
-
Balance workshops to learn getting up from the floor for older adults living at home
This pilot study tests a balance training program that includes a module on getting up from the floor for people over 65 who live at home and have fallen or feel unsteady.
-
ZEPU-AI3 Lower Limb Feedback Training and Evaluation Robot in Rehab
This pilot trial tests whether adding the ZEPU-AI3 robotic leg training with real-time feedback to standard rehab helps adults with lower limb motor problems from stroke, spinal cord injury, or similar conditions.
-
Wearable sensory prosthesis to improve coordination, walking, and activity
This study tests whether the Walkasins sensory device helps adults with peripheral neuropathy walk more and move more, by wearing the device daily for about 10 weeks.
-
Diet to reduce pain from diabetic peripheral neuropathy
This compares a whole-food, plant-based, no-added-oil diet with usual medications to see if it lowers pain and improves nerve symptoms in adults with painful diabetic neuropathy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.